Shedding light on reimbursement policies of companion diagnostics in European countries
dc.contributor.author | Govaerts, Laurenz | |
dc.contributor.author | Simoens, Steven | |
dc.contributor.author | Van Dyck, Walter | |
dc.contributor.author | Huys, Isabelle | |
dc.date.accessioned | 2020-04-26T11:35:58Z | |
dc.date.available | 2020-04-26T11:35:58Z | |
dc.date.issued | 2020 | en_US |
dc.identifier.issn | 1098-3015 | |
dc.identifier.doi | 10.1016/j.jval.2020.01.013 | |
dc.identifier.uri | http://hdl.handle.net/20.500.12127/6482 | |
dc.description.abstract | Ensuring access to precision medicine has been an issue because in some European countries, desynchronized reimbursement decision-making occurs between the medicine and the companion diagnostic (CDx). This has resulted in cases in which precision medicine is reimbursed but not the CDx. In overcoming this issue, an alignment of the decision-making process for reimbursement between the 2 entities should be considered. As pharmaceutical reimbursement procedures are meticulously covered in the literature, we set out to systematically map in vitro diagnostic (IVD) reimbursement procedures and identify policies for aligning these procedures with the pharmaceutical reimbursement procedures. | en_US |
dc.description.sponsorship | This research was funded by Research Foundation Flanders through means of a doctoral scholarship (ID: 1S94318N). | |
dc.language.iso | en | en_US |
dc.publisher | Elsevier | en_US |
dc.subject | Companion Diagnostics | en_US |
dc.subject | In Vitro Diagnostics | en_US |
dc.subject | Precision Medicine | en_US |
dc.subject | Reimbursement | en_US |
dc.title | Shedding light on reimbursement policies of companion diagnostics in European countries | en_US |
dc.identifier.journal | Value in Health | en_US |
dc.source.volume | 23 | |
dc.source.issue | 5 | |
dc.source.beginpage | 606 | |
dc.source.endpage | 615 | |
dc.contributor.department | Department of Pharmaceutical and Pharmacological Sciences, Catholic University of Leuven, Leuven, Belgium | en_US |
dc.contributor.department | Department of Pharmaceutical and Pharmacological Sciences, Catholic University of Leuven, Leuven, Belgium | en_US |
vlerick.knowledgedomain | Special Industries : Healthcare Management | en_US |
vlerick.typearticle | Vlerick strategic journal article | en_US |
vlerick.vlerickdepartment | TOM | en_US |
dc.identifier.vperid | 219312 | en_US |
dc.identifier.vperid | 31183 | en_US |